Issue 8, 2007

Novel strategies for the synthesis of anthrapyranantibiotics: discovery of a new antitumor agent and total synthesis of (S)-espicufolin

Abstract

Two high-yielding strategies for the synthesis of 4H-anthra[1,2-b]pyran antibiotics have been developed giving access to novel antitumor agent 24 (ED50 1.5 µM) and to (S)-espicufolin (3). A key step for the assembly of the tetracyclic 4H-anthra[1,2-b]pyran-4,7,12-trione skeleton is the nucleophilic addition of an aryl lithium species onto an aldehyde which allows the introduction of either an ynone or 1,3-diketo side chain, serving as precursors for an acid-catalysed cyclisation.

Graphical abstract: Novel strategies for the synthesis of anthrapyran antibiotics: discovery of a new antitumor agent and total synthesis of (S)-espicufolin

Supplementary files

Article information

Article type
Paper
Submitted
18 Jan 2007
Accepted
20 Feb 2007
First published
14 Mar 2007

Org. Biomol. Chem., 2007,5, 1191-1200

Novel strategies for the synthesis of anthrapyran antibiotics: discovery of a new antitumor agent and total synthesis of (S)-espicufolin

L. F. Tietze, K. M. Gericke, R. R. Singidi and I. Schuberth, Org. Biomol. Chem., 2007, 5, 1191 DOI: 10.1039/B700838D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements